Case Report

Valproic Acid-induced Eosinophilic Pleural Effusion

Authors: Jeffrey D. Kravetz, MD, Daniel G. Federman, MD

Abstract

Valproic acid is a carboxylic acid used for the treatment of both seizure and mood disorders. Its association with pleural fluid eosinophilia has been reported once in the English language literature. We present another case of valproic acid-induced pleural fluid eosinophilia associated with fever and peripheral blood eosinophilia. Extensive evaluation failed to reveal any other cause of eosinophilic pleural effusion, and the effusion resolved with discontinuance of valproic acid. Rechallenge with valproic acid produced recurrent symptoms. Valproic acid should be considered a possible cause of eosinophilic pleural effusion.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Rubins JB, Rubin, HB. Etiology and prognostic significance of eosinophilic pleural effusions: A prospective study. Chest 1996; 110: 1271–1274.
 
2. Kaufman J, O'Shaughnessy IM. Eosinophilic pleural effusion associated with valproic acid administration. South Med J 1995; 88: 881–882.
 
3. Mattson SB. Monosymptomatic exudative pleurisy in persons exposed to asbestos dust. Scand J Respir Dis 1975; 56: 263–272.
 
4. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, Hidalgo-Ramirez M, Perpina-Tordera M, Sanchis-Moret F, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000; 15: 166–169.
 
5. Jeanfaivre T, Cimon B, Tolstuchow N, De Gentile L, Chabasse D, Tuchais E. Pleural effusion and toxocariasis. Thorax 1996; 51: 106–107.
 
6. Goyal SB. Intestinal strongyloidiasis manifesting as eosinophilic pleural effusion. South Med J 1998; 91: 768–769.
 
7. Emad A. Exudative eosinophilic pleural effusion due to Strongyloides stercoralis in a diabetic man. South Med J 1999; 92: 58–60.
 
8. Samman YS, Wali SO, Abdelaal MA, Gangi MT, Krayam AB. Chronic eosinophilic pneumonia presenting with recurrent massive bilateral pleural effusion: Case report. Chest 2001; 119: 968–970.
 
9. Tonnelier JM, Mocquard Y, Broch C, Vandhuick O, Goas P, Goas JY. Febrile pleuropericarditis during valproic acid treatment [in French]. Presse Med 2001; 30: 62–63.
 
10. Felz MW, Haviland-Foley DJ. Eosinophilic pleural effusion due to dantrolene: Resolution with steroid therapy. South Med J 2001; 94: 502–504.
 
11. Trisolini R, Dore R, Biagi F, Luinetti O, Pochetti P, Carrabino N, et al. Eosinophilic pleural effusion due to mesalamine: Report of a rare occurrence. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 288–291.
 
12. Behnia M, Dowdeswell I, Vakili S. Pleural fluid and serum eosinophilia: Association with fluoxetine hydrochloride. South Med J 2000; 93: 611–613.
 
13. Tzanakis N, Bouros D, Siafakas N. Eosinophilic pleural effusion due to gliclazide. Respir Med 2000; 94: 94.
 
14. Milleron BJ, Valcke J, Akoun GM, Mayaud CM. Isotretinoin-related eosinophilic pleural effusion. Chest 1996; 110: 1128.
 
15. Bunker CB, Sheron N, Maurice PD, Kocjan G, Johnson NM, Dowd PM. Isotretinoin and eosinophilic pleural effusion. Lancet 1989; 1: 435–436.